drugset / Trial / NCT04287205

The Effect of Dydrogesterone on Sexual Function in Women With Endometriosis

NCT04287205

NaSingle-groupOpen-labelTreatment

Summary

This study aimed to assess the effects of dydrogesterone on sexual function in women with endometriosis using Female Function Sexual Index (FSFI).

Timeline

Start
2019-04-20
Primary completion
2020-02-27
Completion
2020-03-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dydrogesterone Other / unclassified 5 mg Oral